Sulindac Tablet
Product Images NDC 72789-373

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Sulindac (NDC 72789-373). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789373 Label (72789373)

Label for Sulindac Tablets USP 150 mg oral tablets, containing 100 tablets per bottle. The label includes storage instructions, dispensing guidance, and manufacturer details for Frontida BioPharm, Inc. It is marketed and packaged by PD-Rx Pharmaceuticals, Inc. The product is prescription-only (Rx Only) and includes a barcode and QR code on the label.*

FDA Label Image

Structure (Sulindac 01)

Chemical structure diagram showing the metabolic conversion of sulindac. It illustrates the transformation from the sulfide form to the sulfoxide (labeled sulindac), and then to the sulfone form, depicting the molecular changes in each step.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.